" /> PR1 Leukemia Peptide Vaccine - CISMeF





Preferred Label : PR1 Leukemia Peptide Vaccine;

NCIt synonyms : Proteinase 3:PR1 Peptide; Leukemia Peptide Vaccine, PR1;

NCIt definition : A cancer vaccine containing PR1, a 9 amino-acid human leukocyte antigen (HLA)-A2 restricted peptide derived from proteinase 3, with potential immunotherapeutic activity. Vaccination with PR1 leukemia peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells expressing proteinase 3, resulting in tumor cell lysis. Often overexpressed in leukemic cells, proteinase 3 is a serine proteinase that activates progelatinase A and is involved in angiogenesis and metastasis.;

UNII : 54XUF2TZ7G;

CAS number : 182253-77-6; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 182253-77-6 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

NSC code : 698102;

Details


You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.